Bio-Rad Laboratories (BIO-B) Income towards Parent Company (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Income towards Parent Company data on file, last reported at -$527.1 million in Q1 2026.

• Income towards Parent Company for Q1 2026 came in at -$527.1 million, down 923.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $168.8 million (up 107.8% YoY), and the FY2025 annual result was $759.9 million, up 141.2% from the prior year.
• Income towards Parent Company declined to -$527.1 million in Q1 2026 per BIO-B's latest filing, from $720.0 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $827.8 million in Q4 2022 and troughed at -$3.4 billion in Q1 2022.
• A 5-year average of -$345.7 million and a median of $64.0 million in 2025 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2024 and 2026: Income towards Parent Company surged 514.75% in 2024, then tumbled 923.59% in 2026.
• A 5-year view of Income towards Parent Company shows it stood at $827.8 million in 2022, then slumped by 57.75% to $349.7 million in 2023, then slumped by 304.67% to -$715.8 million in 2024, then jumped by 200.59% to $720.0 million in 2025, then sank by 173.21% to -$527.1 million in 2026.
• Business Quant data shows BIO-B's Income towards Parent Company at -$527.1 million in Q1 2026, $720.0 million in Q4 2025, and -$341.9 million in Q3 2025.